01-

The Aga Khan University Hospital - Laboratory Investigations

'late Patient Identification & Location
(2/13
G
Physician ' 119
356-99-02
Relevant Clinical Information
111
M 16042001 042021
Previous Antibiotics Therapy

CiteAlAA *.- 1

Specimen Specimen

HAEMATOLOGY I MICROBIOLOGY l /
CBC Complete Blood Cotint BLCS . Blood Culture
WBC • White Blood Cells f
BI -. Blood Indices I
(RBC,VICV, MCH: MCHC) UCS Urine Culture and iensi\
ity
• I-1BHCT HB & Haematocrit
PLT Platelet Count /
Midstream
DLC • Differential (WBC) . ' Catheterized •,/
ESR ESR
Supra-Pubic Aspirate
MP Malarial Paraites
SCS Stool Culture and Sensivity
LAP LeucocS - - - •- Phosphatase
•
BM Bone Marro Other:
BONET _21/47
Bone Treplline
PT PT MICROBIOLOGY II (Stool)
APTT APTT SDR' Soot DR (Faeces)
MIXIT Mixing te.t (PT & APTT) SOB Stool Occult Blood ,
FDP FDP STOORS Stool Reducing Substance'
FACTA Factory 'Assay STOOFG S-iool Fat Globules
PLATA Platele Aggregation Test MICROBIOLOGY III (Urine)
HBEL Hb El: trophoresis UDR Urine Detailed Report
G6PD G6P (Screening Test). - URRS - Reducing Substance
IRON Iron URBS Bile Salt
PER in URBP Bile Pigment f
TIBC Iron Bidin. Capacity
MICROBIOLOGY IV`
HAE • TOLOGY II
Specimen
HBP • Ifffi atitis B profile /
HAVABM .atitis A Antibody (IgM) . 7
FS . ,--ungal Smear t
HBSAG patitis B Surface Anti en i
HEPSAB FC . Fungal Cultur
Hepatitis B Surface Antibody
COREG. H titi B C A ti... . (I. MICROBIOLOCY V
COREM Hepatitis B Core Antibody (IgM) Specimen
HCV Hepatitis C Antibodies -
HPE Hepatitis E Antibodies AFBS APB SME •R
ANA . Anti-Nuclear Antibody AFBC AFB CU URE
A DNA Anti D.N.A. MICROBI • OGY VI
RA ASO . i.ntistr: • olysin 0 tz
Rheumatoid Arthritis (RA)
Factor (Qualitative) CRP C Re. tive Protein
,
HIV HIV Screening Test (ELISA) RPR . VD1=1,. / RPR .0
HAEMATOLOGY III WIDAL W I DAL
•.ABO ABO Blood Group & Rh. Factor TD l'yptii Dot :•---/
,:•Ni
SCREEN Antibody Screening MT Mantoux Test /^0.
OTHER TESTS OTHER TESTS

I.C.N 218175

c
4
CJ The Aga Khan University Hospital
CULTURE & SENSITIVITY SAMPLE PROCESSING SHEET
356-99-02
FAHIM,M. .
Form #: LAB- MIC-PRO-001F1 Issuance Date: 01/01/2016 Revision Date: 01/01/2020

Section/Region: Clinical Microbiology Area/Bench: Bacteriology Year/ Month: 2020/2021 11111111N /v1/1

Nugent Score(N-Score) Specimen N (Paecis;

Container: Sterile top, Syringe, Swab, Trac9Zube, Bactec
Lactobacillus Gardnerella Mobiluncus N-Score Total
Anaerobic/ • erobic bottle)
Gram Positive bacilli Small gram variable bacilli Curved gram negative rods
Numerous (>30) N score =0 Numerous (>30) N score =4 Numerous (>30) score =2 Sample Vol: Appearance:
Moderate (5-30) N score =1 Moderate (5-30) N score = 3 Moderate (5-30) N= score = 2
Media Inoc ated:
Few (1-4) N score =2 Few (1-4) N score =2 Few (1-4) N score =1
Rare (<1) N score = 3 Rare (<1) N score =1 Rare (<1) N score =1 CO2 • 0 B'NA GC HBCNA SBA/HTM
Nil (0) N score = 4 Nil (0) N score = 0 Nil (0) N score = 0 37°C C TRIPLATE CLED MSA XLD/TCBS
01 BHI / APW SF BIGGY
42°C• P ,- ANAEAROBIC: SBA ,
stA Date:
nn
Initials:
Microscopy Morphology

PUS RBC SQU COCCI BACILLI NUGENT

SCORE
GRAM+ GRAM- GRAM - GRAM+

Al •• it )%"-- )\ icV 114

Budding Ye ..t Cells Pseudoh hae: El

Hyphae: As- state ❑ Septate:
Clue Cells: India ink:
Wet Mount: KLB.
Partial Acid ast :
Positive Con ol: Negative Control:
Initials. Date:
Direct Se isit vities:

History:

Informed: Pager/ Ph#

Read Back: e No 11

B: Date:
Objective Rare Few Moderate Numerolls

100X Organism <1 1-5 6-30 >30 \

COMMENTS: 100X Cells <1 1-5 5-10 >10

10X Cells <1 1-9 10-25 >25

Initials: Consultant: Date

Technologist:

Clinical Laboratories - Controlled Document

 k%
Ar •i::-;;L.32.eLvL;L:i
t
logo The Aga Khan University Hospital
CULTURE & SENSITIVITY SAMPLE PROCESSING SHEET

Form #: LAB- MIC-PRO-001F1 Issuance Date: 01/01/2016 Revision Date: 01/01/2020 Revision #: 02
Section/Region: Clinical Microbiology Area/Bench: Bacteriology Year/ Month: 2020/2021 Page #: 2 of 2

Tech
CIVUBHI S/C Tech
DATE CULTURE READING CM/BHI APP
A AN
CL/TR
2(4111t1 PL ah 0(--
1 1 .v- - it_____ al--
i
\jC. ()

DATE ORGANISMS CAT OX ID KB VK Tech

,..........
`-2--t-k1 NttF — SIMCUT RV ,
ir CI •...- $1‘19 '
f

•-....- Aerobic Subculture:

SIMCUT
Primary Anaerobe:

SIMCUT Anaerobic Subculture:

Final Identification
/"."N
'),tit Li( tkh 2-- SIICOF 1.
el PSP/PSF
--f-1
2.

3.
C M P DCO2
4.

B.E/NACL 5.

6.

OP CO2
Sensitivitie

XV X V cot

I
Additional Work: M.EM ,S F/6 tC
I 10B

2
nA,r EO
Initials: Consultant: Date
11
iC 41'0
Technologist:

Clinical Laboratories - Controlled Document

bioMerieux Customer: Laboratory Report Printed Apr 25, 2021 08:43 PKT
System #: Printed by: LEfbadmin

Isolate: bt3936-1 (Approved) Bench: AKUH URINE

Card Type: AST-N222 Bar Code: 6221426103115895 Testing Instrument: 00000B4D3473 (1885)
Setup Technologist: Laboratory Administrator(Labadmin)
Organism Quantity: Selected Organism: Acinetobacter spp

Action Name (User ID) Date/Time Comment

Reviewed by: (Labadmin) Apr 25, 2021 08:43 PKT

Installed VITEK 2 Systems Version: 08.01

MIC Interpretation Guideline: Copy of Global CLSI-based Therapeutic Interpretation Guideline: NATURAL RESISTANCE
AES Parameter Set Name: Copy of Global CLSI-based+Natural Resistance AES Parameter Last Modified: Jun 9, 2020
13:14 PKT

Page 2 of 2
bioMerieux Customer: Laboratory Report Printed Apr 25, 2021 08:43 PKT
System #: Printed by: Labadmin

Isolate: bt3936-1 (Approved) Bench: AKUH URINE

Card Type: AST-N222 Bar Code: 6221426103115895 Testing Instrument: 00000B4D3473 (1885)
Setup Technologist: Laboratory Administrator(Labadmin)
Organism Quantity: Selected Organism: Acinetobacter spp

Comments:

Identification Information
Organism Origin Technologist
Acinetobacter spp
Selected Organism
Entered: Apr 24, 2021 13:32 PKT By: Labadmin
Analysis Messages:

Lot Oct 22, 2021 12:00

Card: AST-N222 6221426103 Expires:
Susceptibility Number: PKT
Information Apr 24, 2021 21:18 Analysis
Completed: Status: Final 7.72 hours
PKT Time:
Antimicrobial MIC Interpretation Antimicrobial MIC Interpretation
Ticarcillin >= 128 R Amikacin 16 S
Ticarcillin/Clavulanic Acid >= 128 R Gentamicin <= 1 S
Piperacillin >= 128 R Tobramycin <= 1 S
Piperacillin/Tazobactam >= 128 R Ciprofloxacin >= 4 R
Ceftazidime >= 64 R Pefloxacin
Cefepime >= 64 R Minocycline <= 1 S
Aztreonam Colistin <= 0.5 S
Imipenem >= 16 R Rifampicin
Trimethoprim/Sulfamethoxaz
Meropenem >= 16 R <= 20 S
ole
+= Deduced drug *= AES modified **= User modified

Copy of Global
AES Findings: Last Modified: Jun 9, 2020 13:14 PKT Parameter Set: CLSI-based+Natural
Resistance
Confidence Level: Analysis no performed r\J

Installed VITEK 2 Systems Version: 08.01

MIC Interpretation Guideline: Copy of Global CLSI-based Therapeutic Interpretation Guideline: NATURAL RESISTANCE
AES Parameter Set Name: Copy of Global CLSI-based+Natural Resistance AES Parameter Last Modified: Jun 9, 2020
13:14 PKT

Page 1 of 2

-WC- 1